 |
Actas Urol Esp (Engl Ed)
- YANG Y, Hu H, Chen L, Zhang H, et al
A new survival model based on ferroptosis-related genes (FRGS) for prognostic
prediction in bladder cancer.
Actas Urol Esp (Engl Ed). 2022 Jun 29. pii: S2173-5786(22)00046.
PubMed
Abstract available
Ann Diagn Pathol
- WENG M, Bai Y, Xu L, Chang C, et al
Comparison of PD-L1 detection methods, platforms and reagents in bladder cancer.
Ann Diagn Pathol. 2022;60:151986.
PubMed
Abstract available
Ann Surg Oncol
- MORI K, Schuettfort VM, Katayama S, Laukhtina E, et al
Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels
in Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy.
Ann Surg Oncol. 2022;29:5307-5316.
PubMed
Abstract available
- BITCON C, Whalen S, Coleman J, Rendon R, et al
Utility of Postoperative Serial Renal Function Monitoring in Patients Undergoing
Radical Cystectomy for Urothelial Carcinoma.
Ann Surg Oncol. 2022;29:5333-5337.
PubMed
Abstract available
- MORI K, Schuettfort VM, Egawa S, Comperat E, et al
ASO Author Reflections: Is Vascular Cell Adhesion Molecule-1 (VCAM-1) a Promising
Biomarker in Urothelial Carcinoma of the Bladder?
Ann Surg Oncol. 2022;29:5317-5318.
PubMed
Anticancer Res
- INOUE S, Sassa N, Kawanishi H, Yuguchi Y, et al
Impact of Histological Variants on Clinical Responses to Pembrolizumab in
Patients With Metastatic Urothelial Cancer.
Anticancer Res. 2022;42:3627-3636.
PubMed
Abstract available
- DENG F, Kong MX, Lai J
Synchronous Penile Squamous Cell Carcinoma, Bladder Urothelial Carcinoma and
Prostate Adenocarcinoma Diagnosed in One Procedure.
Anticancer Res. 2022;42:3601-3605.
PubMed
Abstract available
- WALLACE B, Dekalo S, Kabha M, Mintz I, et al
Can We Predict a Higher Risk of Urothelial Bladder Cancer With a Simple Blood
Test?
Anticancer Res. 2022;42:3569-3573.
PubMed
Abstract available
Arch Ital Urol Androl
- MEHRNOUSH V, De Lima SG, Kotb A, Hyndman ME, et al
The association of bladder cancer and Cannabis: A systematic review.
Arch Ital Urol Androl. 2022;94:248-251.
PubMed
Abstract available
- ARIAFAR A, Salehipour M, Zeyghami S, Rezaei M, et al
The effect of retroperitonealization of ureteroileal anastomosis on perioperative
complications of radical cystectomy with ileal conduit urinary diversion.
Arch Ital Urol Androl. 2022;94:150-154.
PubMed
Abstract available
- MALINARIC R, Mantica G, Balzarini F, Terrone C, et al
Extraperitoneal cystectomy with ureterocutaneostomy derivation in fragile
patients - should it be performed more often?
Arch Ital Urol Androl. 2022;94:144-149.
PubMed
Abstract available
- PEREIRA JN, Reis JD, Braga I, Freitas R, et al
Variant histologies of urothelial carcinoma: Does it change the survival outcomes
in patients managed with radical cystectomy?
Arch Ital Urol Androl. 2022;94:138-143.
PubMed
Abstract available
- LEONARDI R, Calarco A, Falcone L, Grasso V, et al
Endoscopic laser en bloc removal of bladder tumor. Surgical radicality and
improvement of the pathological diagnostic accuracy.
Arch Ital Urol Androl. 2022;94:134-137.
PubMed
Abstract available
Asian J Endosc Surg
- MORIZANE S, Honda M, Yumioka T, Iwamoto H, et al
Technique of en bloc resection of the membranous urethra and bladder during
robot-assisted radical cystectomy in patients without simultaneous urethrectomy.
Asian J Endosc Surg. 2022;15:683-687.
PubMed
Abstract available
Biochem Biophys Res Commun
- LIU X, He Y, Tong Y, Huang Q, et al
PODNL1 promotes cell migration and regulates the epithelial/mesenchymal
transition process in bladder cancer.
Biochem Biophys Res Commun. 2022;620:165-172.
PubMed
Abstract available
Biol Pharm Bull
- ZHOU Q, Wu WW, Yu CL, Wang P, et al
Saikosaponin A Inhibits Growth of Human Bladder Carcinoma T24 and 5637 Cells Both
in Vitro and in Vivo.
Biol Pharm Bull. 2022;45:863-871.
PubMed
Abstract available
BJU Int
- DADIKHI K, Mueller F, Montani M, Thalmann GN, et al
Case of the Month from the University Hospital of Bern, Switzerland: Urothelial
carcinoma in an orthotopic neobladder: reported cases and pathophysiological
hypotheses.
BJU Int. 2022;130:38-42.
PubMed
- LOIZZO D, Pandolfo SD, Del Giudice F, Cerrato C, et al
Ureteroscopy and tailored treatment of upper tract urothelial cancer: recent
advances and unmet needs.
BJU Int. 2022;130:35-37.
PubMed
- MAIBOM SL, Roder MA, Aasvang EK, Rohrsted M, et al
Open vs robot-assisted radical cystectomy (BORARC): a double-blinded, randomised
feasibility study.
BJU Int. 2022;130:102-113.
PubMed
Abstract available
- AHMADI H, Ladi-Seyedian SS, Konety B, Pohar K, et al
Role of blue-light cystoscopy in detecting invasive bladder tumours: data from a
multi-institutional registry.
BJU Int. 2022;130:62-67.
PubMed
Abstract available
- GRAHN A, Eisfeldt J, Malm C, Foroughi Asl H, et al
Genomic profile - a possible diagnostic and prognostic marker in upper tract
urothelial carcinoma.
BJU Int. 2022;130:92-101.
PubMed
Abstract available
BMC Cancer
- KIM GT, Kim EY, Shin SH, Lee H, et al
Improving anticancer effect of aPD-L1 through lowering neutrophil infiltration by
PLAG in tumor implanted with MB49 mouse urothelial carcinoma.
BMC Cancer. 2022;22:727.
PubMed
Abstract available
Br J Cancer
- TOMIYAMA E, Fujita K, Matsuzaki K, Narumi R, et al
EphA2 on urinary extracellular vesicles as a novel biomarker for bladder cancer
diagnosis and its effect on the invasiveness of bladder cancer.
Br J Cancer. 2022 Jul 6. pii: 10.1038/s41416-022-01860.
PubMed
Abstract available
Br J Dermatol
- PENNY CL, Quow K, Rundle CW, Al-Rohil RN, et al
Clinical and direct immunofluorescence characteristics of cutaneous toxicity
associated with enfortumab vedotin.
Br J Dermatol. 2022 Jan 19. doi: 10.1111/bjd.21022.
PubMed
Cancer Drug Resist
- RUIZ DE PORRAS V
Natural bioactive compounds: a potential therapeutic strategy to sensitize
bladder cancer to cisplatin treatment?
Cancer Drug Resist. 2022;5:339-343.
PubMed
Abstract available
Comput Biol Med
- ZHENG X, Xu H, Lin T, Tan P, et al
CD93 orchestrates the tumor microenvironment and predicts the molecular subtype
and therapy response of bladder cancer.
Comput Biol Med. 2022;147:105727.
PubMed
Abstract available
Comput Math Methods Med
- HU K, Zhu J, Li P, Ying L, et al
Multiorientation Simultaneous Computation of Back-Projection CT Image
Reconstruction Algorithm in Staging Diagnosis of Bladder Cancer.
Comput Math Methods Med. 2022;2022:6731491.
PubMed
Abstract available
Contrast Media Mol Imaging
- KE H, Qiu D, Cong Z
Prognosis Analysis and Perioperative Research of Elderly Patients with
Non-Muscle-Invasive Bladder Cancer under Computed Tomography Image of
Three-Dimensional Reconstruction Algorithm.
Contrast Media Mol Imaging. 2022;2022:6168528.
PubMed
Abstract available
Curr Med Sci
- HU QG, Yang Z, Chen JW, Kazobinka G, et al
MiR-183-5p-PNPT1 Axis Enhances Cisplatin-induced Apoptosis in Bladder Cancer
Cells.
Curr Med Sci. 2022 Jul 5. pii: 10.1007/s11596-022-2580.
PubMed
Abstract available
Diagn Cytopathol
- YUAN L, Gero M, Zia S, Aryal SC, et al
Cyto-histo correlation and false-negative urine: Before and after the Paris
system for reporting urinary cytology.
Diagn Cytopathol. 2022;50:404-410.
PubMed
Abstract available
Dis Markers
- CHI BJ, Sun Y, Quan LL, Zhao JT, et al
Metformin Can Enhance the Inhibitory Effect of Olaparib in Bladder Cancer Cells.
Dis Markers. 2022;2022:5709259.
PubMed
Abstract available
Discov Oncol
- HUANG W, Zhang C, Xiong S, Zhou X, et al
miR-1307-5p suppresses proliferation and tumorigenesis of bladder cancer via
targeting MDM4 and the Hippo signaling pathway.
Discov Oncol. 2022;13:57.
PubMed
Abstract available
Eur Rev Med Pharmacol Sci
- ZHAO X, Li D, Zhao ST, Zhang Y, et al
MiRNA-616 aggravates the progression of bladder cancer by regulating cell
proliferation, migration and apoptosis through downregulating SOX7.
Eur Rev Med Pharmacol Sci. 2022;26:4158.
PubMed
Abstract available
Eur Urol
- ADELEKE S, Tocco B, Kasivisvanathan V
Re: Chemoradiotherapy in Muscle-invasive Bladder Cancer (BC2001): 10-year
Follow-up of a Phase 3 Randomised Controlled Trial.
Eur Urol. 2022 Jul 1. pii: S0302-2838(22)02470.
PubMed
- TAKAHASHI T
Re: Ekaterina Laukhtina, Shahrokh F. Shariat. Phase II Study of Gemcitabine and
Split-dose Cisplatin plus Pembrolizumab as Neoadjuvant Therapy Before Radical
Cystectomy in Patients with Muscle-invasive Bladder Cancer. Eur Urol. In press.
https://doi.o
Eur Urol. 2022 Jul 1. pii: S0302-2838(22)02466.
PubMed
Eur Urol Focus
- STANGL-KREMSER J, Lambertini L, Di Maida F, Martinez-Fundichely A, et al
Enhancing Recovery After Major Bladder Cancer Surgery: Comprehensive Review and
Assessment of Application of the Enhanced Recovery After Surgery Guidelines.
Eur Urol Focus. 2022 Jun 27. pii: S2405-4569(22)00133.
PubMed
Abstract available
Eur Urol Oncol
- HEMENWAY G, Lewis B, Ghatalia P, Anari F, et al
Neoadjuvant Chemotherapy with Accelerated Methotrexate, Vinblastine, Doxorubicin,
and Cisplatin in Patients with Muscle-invasive Bladder Cancer: A Retrospective
Age-stratified Analysis on Safety and Efficacy.
Eur Urol Oncol. 2022 Jul 2. pii: S2588-9311(22)00107.
PubMed
Abstract available
Evid Based Complement Alternat Med
- SHANG X, Na X, Wang L, Yang Z, et al
Evaluation of a Dual PI3K/mTOR Inhibitor PF-04691502 against Bladder Cancer
Cells.
Evid Based Complement Alternat Med. 2022;2022:8110796.
PubMed
Abstract available
Front Cell Dev Biol
- WANG C, Wan H, Zhang H, Yang B, et al
Characterization of Ligand-Receptor Pair in Bladder Cancer Develops a Validated
Scoring Model for Prognosis and Treatment Response.
Front Cell Dev Biol. 2022;10:915798.
PubMed
Abstract available
Front Genet
- ZHANG Y, Wang Y, Wang J, Zhang K, et al
The Immune Cell Infiltration Patterns and Characterization Score in Bladder
Cancer to Identify Prognosis.
Front Genet. 2022;13:852708.
PubMed
Abstract available
Front Med (Lausanne)
- KOLL FJ, Schwarz A, Kollermann J, Banek S, et al
CK5/6 and GATA3 Defined Phenotypes of Muscle-Invasive Bladder Cancer: Impact in
Adjuvant Chemotherapy and Molecular Subtyping of Negative Cases.
Front Med (Lausanne). 2022;9:875142.
PubMed
Abstract available
Front Oncol
- PANG K, Dong Y, Hao L, Shi ZD, et al
ERH Interacts With EIF2alpha and Regulates the EIF2alpha/ATF4/CHOP Pathway in
Bladder Cancer Cells.
Front Oncol. 2022;12:871687.
PubMed
Abstract available
Gene
- LIU Z, Liu X, Liu F, Zhao H, et al
The comprehensive and systematic identification of BLCA-specific SF-regulated,
survival-related AS events.
Gene. 2022;835:146657.
PubMed
Abstract available
IJU Case Rep
- GOTO Y, Tanaka S, Maruo M, Sugawara S, et al
Pathological complete response of plasmacytoid variant bladder cancer to
pembrolizumab following genomic analysis.
IJU Case Rep. 2022;5:304-307.
PubMed
Abstract available
Indian J Surg Oncol
- KUMAR P, Sharma S, Sundriyal D, Navria SC, et al
An Institution-Based Demographic Study of Urinary Bladder Cancer from North
India.
Indian J Surg Oncol. 2022;13:432-434.
PubMed
Abstract available
Int J Med Robot
- YANG X, Wang Y, Jiao W, Li J, et al
Application of 5G technology to conduct tele-surgical robot-assisted laparoscopic
radical cystectomy.
Int J Med Robot. 2022;18:e2412.
PubMed
Abstract available
Int J Mol Med
- JI J, Li H, Chen J, Wang W, et al
Lamin B2 contributes to the proliferation of bladder cancer cells via activating
the expression of cell division cycleassociated protein 3.
Int J Mol Med. 2022;50.
PubMed
Abstract available
Int J Radiat Oncol Biol Phys
- CHARGARI C, Haie-Meder C, Espenel S, Garcia MA, et al
Brachytherapy for Pediatric Patients at Gustave Roussy Cancer Campus: A Model of
International Cooperation for Highly Specialized Treatments.
Int J Radiat Oncol Biol Phys. 2022;113:602-613.
PubMed
Abstract available
Int J Surg Pathol
- TAKADA-OWADA A, Fuchizawa H, Kijima T, Ishikawa M, et al
Cryptococcal Prostatitis Forming Caseous and Suppurative Granulomas Diagnosed by
Needle Biopsy: A Case Report.
Int J Surg Pathol. 2022;30:586-589.
PubMed
Abstract available
Int J Urol
- TOGASHI K, Hatakeyama S, Yoneyama T, Hamaya T, et al
Effect of active anticancer therapy on serologic response to SARS-CoV-2 BNT162b2
vaccine in patients with urothelial and renal cell carcinoma.
Int J Urol. 2022;29:733-739.
PubMed
Abstract available
- SARI MOTLAGH R, Schuettfort VM, Mori K, Katayama S, et al
Prognostic impact of insulin-like growth factor-I and its binding proteins,
insulin-like growth factor-I binding protein-2 and -3, on adverse
histopathological features and survival outcomes after radical cystectomy.
Int J Urol. 2022;29:676-683.
PubMed
Abstract available
- MASTROIANNI R, Simone G
Editorial Comment to Prognostic impact of insulin-like growth factor-I and its
binding proteins, insulin-like growth factor-I binding protein-2 and -3, on
adverse histopathological features and survival outcomes after radical
cystectomy.
Int J Urol. 2022;29:684.
PubMed
- ISHIYAMA Y
Editorial Comment to Impact of early postoperative creatinine increase on
mid-term renal function after cystectomy.
Int J Urol. 2022;29:724.
PubMed
- KITA Y, Ito K, Sano T, Hashimoto K, et al
Clinical practice pattern in patients with advanced urothelial cancer who had
progressed on pembrolizumab in the pre-enfortumab vedotin era.
Int J Urol. 2022;29:647-655.
PubMed
Abstract available
Investig Clin Urol
- LEE HW, Seo HK
Clinical implications and practical considerations for poly-ADP-ribose polymerase
inhibitors as a new horizon for the management of urothelial carcinoma of the
bladder.
Investig Clin Urol. 2022;63:369-372.
PubMed
J Adv Res
- LIU S, Chen X, Lin T
Emerging strategies for the improvement of chemotherapy in bladder cancer:
Current knowledge and future perspectives.
J Adv Res. 2022;39:187-202.
PubMed
Abstract available
J Chromatogr A
- FANG T, Tang C, Yin J, Wang H, et al
Magnetic multi-enzyme cascade combined with liquid chromatography tandem mass
spectrometry for fast DNA digestion and quantitative analysis of
5-hydroxymethylcytosine in genome of human bladder cancer T24 cells induced by
tetrachlorobenzoquinone.
J Chromatogr A. 2022;1676:463279.
PubMed
Abstract available
J Immunother Cancer
- MOREO E, Uranga S, Pico A, Gomez AB, et al
Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive
established bladder tumors.
J Immunother Cancer. 2022;10.
PubMed
Abstract available
J Rheumatol
- YILDIRIM R, Cansu DU, Korkmaz C
A Case of Scleromyxedema Development Following Intravesical Bacillus
Calmette-Guerin Administration.
J Rheumatol. 2022;49:858-859.
PubMed
J Transl Med
- SONG Q, Yu H, Cheng Y, Han J, et al
Bladder cancer-derived exosomal KRT6B promotes invasion and metastasis by
inducing EMT and regulating the immune microenvironment.
J Transl Med. 2022;20:308.
PubMed
Abstract available
Mayo Clin Proc
- GUPTA S, Erickson LA
Postirradiation Angiosarcoma of the Urinary Bladder.
Mayo Clin Proc. 2022;97:1406-1408.
PubMed
Medicine (Baltimore)
- ZHANG L, Ding D, Liu J, Liu J, et al
Identification of prognostic and immunotherapy-related eRNA ID2-AS1 in bladder
cancer.
Medicine (Baltimore). 2022;101:e29759.
PubMed
Abstract available
- ZENG W, Swee DS
Severe and refractory hypocalcaemia secondary to osteoblastic bone metastases in
bladder signet ring carcinoma: A case report and literature review.
Medicine (Baltimore). 2022;101:e29731.
PubMed
Abstract available
- CHEN H, Wang Z, Yang N, Zhang J, et al
Decorin inhibits proliferation and metastasis in human bladder cancer cells by
upregulating P21.
Medicine (Baltimore). 2022;101:e29760.
PubMed
Abstract available
Nat Rev Urol
- MARTIN A, Woolbright BL, Umar S, Ingersoll MA, et al
Bladder cancer, inflammageing and microbiomes.
Nat Rev Urol. 2022 Jul 7. pii: 10.1038/s41585-022-00611.
PubMed
Abstract available
Oncogene
- LIU F, Zhang H, Xie F, Tao D, et al
Correction: Hsa_circ_0001361 promotes bladder cancer invasion and metastasis
through miR-491-5p/MMP9 axis.
Oncogene. 2022 Jul 7. pii: 10.1038/s41388-022-02358.
PubMed
Oncologist
- GIM G, Kim Y, Park Y, Kim MJ, et al
Response to Nivolumab and Ipilimumab in Microsatellite Instability-High (MSI-H)
Cervical Carcinoma with Acquired Resistance to Pembrolizumab: A Case Report and
Literature Review.
Oncologist. 2022;27:525-531.
PubMed
Abstract available
Pharmacoepidemiol Drug Saf
- KEMP-CASEY A, Mintzes B, Morrow RL, Dormuth CR, et al
Pioglitazone use in Australia and the United Kingdom following drug safety
advisories on bladder cancer risk: an interrupted time series study.
Pharmacoepidemiol Drug Saf. 2022 Jul 5. doi: 10.1002/pds.5508.
PubMed
Abstract available
PLoS Genet
- CHEN M, Chan RWY, Cheung PPH, Ni M, et al
Fragmentomics of urinary cell-free DNA in nuclease knockout mouse models.
PLoS Genet. 2022;18:e1010262.
PubMed
Abstract available
PLoS One
- GULYAS D, Kovacs G, Jankovics I, Meszaros L, et al
Effects of the combination of a monoclonal agonistic mouse anti-OX40 antibody and
toll-like receptor agonists: Unmethylated CpG and LPS on an MB49 bladder cancer
cell line in a mouse model.
PLoS One. 2022;17:e0270802.
PubMed
Abstract available
- GLEICHENHAGEN J, Arndt C, Casjens S, Topfer C, et al
Exploring solid-phase proximity ligation assay for survivin detection in urine.
PLoS One. 2022;17:e0270535.
PubMed
Abstract available
Sci Rep
- TAN W, Yuan Y, Huang H, Ma J, et al
Comprehensive analysis of autophagy related long non-coding RNAs in prognosis,
immunity, and treatment of muscular invasive bladder cancer.
Sci Rep. 2022;12:11242.
PubMed
Abstract available
Ther Adv Med Oncol
- GUO Y, Zheng Z, Zhang W, Mao S, et al
Gender dimorphism in survival of patients with lymph node metastasis of bladder
cancer.
Ther Adv Med Oncol. 2022;14:17588359221108690.
PubMed
Abstract available
World J Surg Oncol
- XU T, Gu W, Wang X, Xia L, et al
Distant metastasis without regional progression in non-muscle invasive bladder
cancer: case report and pooled analysis of literature.
World J Surg Oncol. 2022;20:226.
PubMed
Abstract available
World J Urol
- PHE V
Bladder Cancer in Neurogenic Patients.
World J Urol. 2022 Jul 8. pii: 10.1007/s00345-022-04089.
PubMed
- RICHTERS A, Leliveld AM, Goossens-Laan CA, Aben KKH, et al
Sex differences in treatment patterns for non-advanced muscle-invasive bladder
cancer: a descriptive analysis of 3484 patients of the Netherlands Cancer
Registry.
World J Urol. 2022 Jul 1. pii: 10.1007/s00345-022-04080.
PubMed
Abstract available
|
AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to
a media sponsorship by
Boehringer Ingelheim.
Design:
|